Published Online
on April 24, 2008

A more recent version of this article appeared on July 1, 2008

This Article Full Text (PDF) All Versions of this Article: 39/7/2174    most recent STROKEAHA.107.509588v1 Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Muir, K. W. Search for Related Content PubMed PubMed Citation Articles by Muir, K. W. Related Collections Antiplatelets Other Stroke Treatment - Medical

Submitted on July 24, 2007
Accepted on November 8, 2007

The PREVAIL Trial and Low-Molecular-Weight Heparin for Prevention of Venous Thromboembolism

Keith W. Muir MD, FRCP^*

From the Division of Clinical Neurosciences, University of Glasgow, Institute of Neurological Sciences, Southern General Hospital, Glasgow, UK.

^* To whom correspondence should be addressed. E-mail: k.muir{at}clinmed.gla.ac.uk.

Key words: antiplatelet agents • venous thromboembolism